Authors:
Plettenberg, A
Albrecht, D
Lorenzen, T
Paech, V
Petersen, H
Fenner, T
Meyer, T
Arndt, R
Hertogs, K
Pauwels, R
Weitzel, T
Stoehr, A
Citation: A. Plettenberg et al., Resistance analyses in HIV infected patients with a history of multiple antiretroviral treatment regimens, SEX TRANS I, 77(6), 2001, pp. 449-452
Authors:
Derom, E
Borgstrom, L
Van Schoor, J
Lofroos, AB
Pauwels, R
Citation: E. Derom et al., Lung deposition and protective effect of terbutaline delivered from pressurized metered-dose inhalers and the turbuhaler in asthmatic individuals, AM J R CRIT, 164(8), 2001, pp. 1398-1402
Authors:
Ludovici, DW
Kukla, MJ
Grous, PG
Krishnan, S
Andries, K
de Bethune, MP
Azijn, H
Pauwels, R
De Clercq, E
Arnold, E
Janssen, PAJ
Citation: Dw. Ludovici et al., Evolution of anti-HIV drug candidates. Part 1: From alpha-anilinophenylacetamide (alpha-APA) to imidoyl thiourea (ITU), BIOORG MED, 11(17), 2001, pp. 2225-2228
Authors:
Ludovici, DW
Kavash, RW
Kukla, MJ
Ho, CY
Ye, H
De Corte, BL
Andries, K
de Bethune, MP
Azijn, H
Pauwels, R
Moereels, HEL
Heeres, J
Koymans, LMH
de Jonge, MR
Van Aken, KJA
Daeyaert, FFD
Lewi, PJ
Das, K
Arnold, E
Janssen, PAJ
Citation: Dw. Ludovici et al., Evolution of anti-HIV drug candidates part 2: Diaryltriazine (DATA) analogues, BIOORG MED, 11(17), 2001, pp. 2229-2234
Authors:
Ludovici, DW
De Corte, BL
Kukla, MJ
Ye, H
Ho, CY
Lichtenstein, MA
Kavash, RW
Andries, K
de Bethune, MP
Azijn, H
Pauwels, R
Lewi, PJ
Heeres, J
Koymans, LMH
de Jonge, MR
Van Aken, KJA
Daeyaert, FFD
Das, K
Arnold, E
Janssen, PAJ
Citation: Dw. Ludovici et al., Evolution of anti-HIV drug candidates. Part 3: Diarylpyrimidine (DAPY) analogues, BIOORG MED, 11(17), 2001, pp. 2235-2239
Authors:
Bullock, GR
Steyaert, I
Bilbe, G
Carey, RM
Kips, J
De Paepe, B
Pauwels, R
Praet, M
Siragy, HM
de Gasparo, M
Citation: Gr. Bullock et al., Distribution of type-1 and type-2 angiotensin receptors in the normal human lung and in lungs from patients with chronic obstructive pulmonary disease, HISTOCHEM C, 115(2), 2001, pp. 117-124
Citation: E. Derom et R. Pauwels, Systemic effects of inhaled fluticasone propionate and budesonide in adultpatients with asthma - From the authors, AM J R CRIT, 161(6), 2000, pp. 2115-2115
Authors:
Borgstrom, L
Bengtsson, T
Derom, E
Pauwels, R
Citation: L. Borgstrom et al., Variability in lung deposition of inhaled drug, within and between asthmatic patients, with a pMDI and a dry powder inhaler, Turbuhaler (R), INT J PHARM, 193(2), 2000, pp. 227-230
Authors:
Hertogs, K
Bloor, S
Kemp, SD
Van den Eynde, C
Alcorn, TM
Pauwels, R
Van Houtte, M
Staszewski, S
Miller, V
Larder, BA
Citation: K. Hertogs et al., Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples, AIDS, 14(9), 2000, pp. 1203-1210
Authors:
Swart, PJ
Harmsen, MC
Kuipers, MI
Van Dijk, AA
Van der Strate, BWA
Van Berkel, PHC
Nuijens, JH
Smit, C
Witvrouw, M
De Clercq, E
De Bethune, MP
Pauwels, R
Meijer, DKF
Citation: Pj. Swart et al., Charge modification of plasma and milk proteins results in antiviral active compounds, J PEPT SCI, 5(12), 1999, pp. 563-576
Authors:
Derom, E
Van Schoor, J
Verhaeghe, W
Vincken, W
Pauwels, R
Citation: E. Derom et al., Systemic effects of inhaled fluticasone propionate and budesonide in adultpatients with asthma, AM J R CRIT, 160(1), 1999, pp. 157-161
Authors:
Breslin, HJ
Kukla, MJ
Kromis, T
Cullis, H
De Knaep, F
Pauwels, R
Andries, K
De Clercq, E
Janssen, MAC
Janssen, PAJ
Citation: Hj. Breslin et al., Synthesis and anti-HIV activity of 1,3,4,5-tetrahydro-2H-1,4-benzodiazepin-2-one (TBO) derivatives. Truncated 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-ones (TIBO) analogues, BIO MED CH, 7(11), 1999, pp. 2427-2436
Authors:
Harrigan, PR
Hertogs, K
Verbiest, W
Pauwels, R
Larder, B
Kemp, S
Bloor, S
Yip, B
Hogg, R
Alexander, C
Montaner, JSG
Citation: Pr. Harrigan et al., Baseline HIV drug resistance profile predicts response to ritonavir-saquinavir protease inhibitor therapy in a community setting, AIDS, 13(14), 1999, pp. 1863-1871
Citation: Me. Wechsler et al., Leukotriene modifiers and Churg-Strauss syndrome - Adverse effect or response to corticosteroid withdrawal?, DRUG SAFETY, 21(4), 1999, pp. 241-251
Authors:
Larder, BA
Bloor, S
Kemp, SD
Hertogs, K
Desmet, RL
Miller, V
Sturmer, M
Staszewski, S
Ren, J
Stammers, DK
Stuart, DI
Pauwels, R
Citation: Ba. Larder et al., A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance, ANTIM AG CH, 43(8), 1999, pp. 1961-1967
Authors:
Miller, V
de Bethune, RP
Kober, A
Sturmer, M
Hertogs, K
Pauwels, R
Stoffels, P
Staszewski, S
Citation: V. Miller et al., Patterns of resistance and cross-resistance to human immunodeficiency virus type 1 reverse transcriptase inhibitors in patients treated with the nonnucleoside reverse transcriptase inhibitor loviride, ANTIM AG CH, 42(12), 1998, pp. 3123-3129